Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:
Find out more about our cookies policy
(+1) 617 896 0213
info@sagentia.com
A white paper by our Innovation and Technology Management group providing a disease centric view of disruptive technologies.
Determining the impact of future technologies is challenging and no more so than in the medical field. Intense research is leading to numerous potential options to diagnose, manage and treat medical conditions. Whilst these approaches are advancing patient care, new, innovative technologies create a high degree of uncertainty in the market - many organisations are finding it increasingly difficult to predict what might happen and when.